🇺🇸 FDA
Pipeline program

Intravenous methylene blue administration

B-1210/173-002

Phase 3 small_molecule active

Quick answer

Intravenous methylene blue administration for Severe Sepsis is a Phase 3 program (small_molecule) at Hospital Authority, Hong Kong with 1 ClinicalTrials.gov record(s).

Program details

Company
Hospital Authority, Hong Kong
Indication
Severe Sepsis
Phase
Phase 3
Modality
small_molecule
Status
active

Clinical trials